| 中文名 | 4-[[6-[2-[(2-喹噁啉羰基)氨基]苯基]咪唑并 [2,1-b]噻唑-3-基]甲基]-1-哌嗪羧酸 1,1-二甲基乙酯 |
|---|---|
| 英文名 | tert-butyl 4-[[6-[2-(quinoxaline-2-carbonylamino)phenyl]imidazo[2,1-b][1,3]thiazol-3-yl]methyl]piperazine-1-carboxylate |
| 中文别名 | 1-BOC-4-[[6-[2-[(2-喹喔啉甲酰基)胺基]苯基]咪唑[2,1-B]噻唑-3-基]甲基]哌嗪 |
| 英文别名 |
4-[[6-[2-[(2-QUINOXALINYLCBONYL)AMINO]PHENYL]IMIDAZO [2,1-B]THIAZOL-3-YL]METHYL]-1-PIPERAZINECBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER
tert-Butyl 4-((6-(2-(quinoxaline-2-cboxamido)phenyl)imidazo-[2,1-b]thiazol-3-yl)methyl)piperazi tert-Butyl 4-((6-(2-(quinoxaline-2-cboxamido)phenyl)imidazo-[2,1-b]thiazol-3-yl)methyl)piperazine-1-cboxylate 1-Boc-4-[[6-[2-[(2-quinoxalinylcbonyl)amino]phenyl]iMidazo[2,1-b]thiazol-3-yl]Methyl]piperazine 1-Piperazinecboxylic acid, 4-[[6-[2-[(2-quinoxalinylcbonyl)amino]phenyl]imidazo[2,1-b]thiazol-3-yl]methyl]-, 1,1-dimethylethyl ester tert-Butyl 4-((6-(2-(quinoxaline-2-cboxamido)phenyl)imidazo-[2,1-b]thiazol-3-yl)methyl)piper |
| 分子式 | C30H31N7O3S |
|---|---|
| 分子量 | 569.67700 |
| 精确质量 | 569.22100 |
| PSA | 133.20000 |
| LogP | 5.25980 |
| 海关编码 | 2934100090 |
|---|
|
~%
925436-46-0 |
| 文献:Sirtris Pharmaceuticals, Inc. Patent: US2008/249103 A1, 2008 ; Location in patent: Page/Page column 35 ; US 20080249103 A1 |
| 上游产品 1 | |
|---|---|
| 下游产品 1 | |
| 海关编码 | 2934100090 |
|---|---|
| 中文概述 | 2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |